59.js","4868","static/chunks/4868-6f49ce1b0a9f5635.js","231","static/chunks/231-4f394f77a0d1e7ca.js","9903","static/chunks/9903-2ec2731c98de1dcf.js","1686","static/chunks/1686-875920cba72b7a2a.js","7239","static/chunks/7239-789f0de8b910cfde.js","1161","static/chunks/1161-02aec766fd43ccf5.js","3188","static/chunks/app/episode/%5BepisodeId%5D/(overview)/page-9786afe733d6104a.js"],"Shownotes"] 16:T583,

In this episode, Douglas Dieterich, MD, leads a panel discussion with Camilla S. Graham, MD, MPH, and Robert Wong, MD, MS, to consider advantages and barriers to universal screening for chronic HBV infection and universal HDV screening in adults with HBV in the United States. Topics include:

Updated CDC recommendations for one-time universal screening for HBV
Addressing patient-, provider-, and system-level barriers to universal HBV screening
Best practices for implementation of HDV screening

Presenters:

Douglas Dieterich, MD
Director, Institute for Liver Medicine

Professor of Medicine

Division of Liver Diseases

Mount Sinai School of Medicine

New York, New York

Camilla S. Graham, MD, MPH
Co-Director, Viral Hepatitis Clinic
Division of Infectious Diseases
Beth Israel Deaconess Medical Center
Harvard Medical School
Boston, Massachusetts

Robert Wong, MD, MS
Clinical Associate Professor
Division of Gastroenterology and Hepatology
Stanford University School of Medicine
Palo Alto, California

Link to full program:
https://bit.ly/3TuqFHI

Link to the slides:
https://bit.ly/4atS42z

1f:T583,

CCO Infectious Disease Podcast

Overview

Outlines

Mindmap

Transcript

Keywords

Highlights

Shownotes

AI Summary